Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 21, 2023 05:32 ET | Source: Growth Plus Reports

Respiratory Syncytial Virus (RSV) Therapeutics Market to Hit US$ 8.73 Billion by 2031 | Exclusive Report by Growth Plus Reports

Newark, New Castle, USA, June 21, 2023 (GLOBE NEWSWIRE) -- A recent report by Growth Plus Reports estimated the global respiratory syncytial virus (RSV) therapeutics market to be worth US$ 1.84...
January 20, 2021 08:42 ET | Source: Fortune Business Insights

Respiratory Syncytial Virus Therapeutics Market worth USD 4,003.4 Million at 30.9% CAGR; Varying Ethnicity and Climate Difference to Boost Demand in Asia Pacific

Pune, India, Jan. 20, 2021 (GLOBE NEWSWIRE) -- The global Respiratory Syncytial Virus Therapeutics Market size is estimated to showcase potential growth owing to its increasing adoption against the...